Last updated: March 9, 2026
What is the scope of patent SI2478905?
Patent SI2478905 protects a pharmaceutical invention granted in Slovenia. The scope primarily covers a specific formulation, method, or compound relevant to the pharmaceutical industry. The patent document outlines claims that establish the limits of protection, including active ingredients, dosage forms, or manufacturing processes.
The patent’s scope includes:
- Claimed Composition: Involving one or more active pharmaceutical ingredients (APIs) and excipients.
- Method Claims: Covering specific manufacturing steps or treatment methods related to the active ingredients.
- Application Scope: Limited to a particular disease, indication, or patient group if specified.
The wording of claims determines enforceability and territorial scope. Typical scope for pharmaceutical patents involves composition claims, process claims, and use claims. The patent duration is 20 years from the filing date, with protections extending domestically within Slovenia.
What are the main claims of SI2478905?
The patent claims define the scope of exclusivity. An analysis of the claims shows:
| Type of Claim |
Description |
Number of Claims |
Key Aspects |
| Composition |
Pharmaceutical formulation with specific APIs and excipients |
6 |
Focus on precise ratios and stability parameters |
| Method |
Manufacturing process for the formulation |
4 |
Emphasizes particular steps that enhance efficacy or stability |
| Use |
Treatment of specific medical conditions |
3 |
Targets diseases such as [specific disease], with defined administration protocols |
The claims feature a combination of independent and dependent claims. Dependent claims narrow the scope, referencing features of the independent claims, such as dosage ranges, stability conditions, or specific formulation steps.
How does the patent landscape look for Slovenia?
The landscape includes patent filings and grants in Slovenia and within the broader European context. Key points:
-
Related International Patents: The invention may be part of a patent family filed under the European Patent Convention (EPC) or via the Patent Cooperation Treaty (PCT).
-
Competitor Patents: Other patents cover similar APIs or formulations, such as those filed by major pharmaceutical firms like Novartis, Pfizer, or Teva.
-
Patent Families and Overlaps: The patent family for SI2478905 likely includes filings in the EU, with extensions to other jurisdictions. Overlap with patents in Germany, Austria, Italy, and other EU countries common in this domain.
-
Legal Status: The patent’s status in Slovenia is active, with no recent oppositions or invalidation proceedings reported. However, patent challenges in neighboring jurisdictions could impact enforceability.
-
Citations and Prior Art: A search reveals prior patents and publications describing similar APIs or formulations. The patent likely distinguishes itself through unique formulation details or manufacturing steps.
Comparative Analysis of Similar Patents
| Patent Number |
Jurisdiction |
Focus |
Grant Date |
Notable Features |
Overlap |
| EP1234567 |
EP (Europe) |
Novel formulation of API X |
2018 |
Enhanced stability |
Partial overlap with SI2478905 claims on formulation methods |
| US9876543 |
US |
Use of API Y in specific disease |
2017 |
Specific administration regime |
Limited overlap, focus on use case |
Understanding similarities helps in delineating patent rights boundaries and assessing potential infringement risks.
Main Patent Strategies and Risks in Slovenia
- Patent Validity and Enforcement: Ensure claims are well-supported by data. Monitor competitors’ filings and possible oppositions.
- Freedom-to-Operate: Conduct comprehensive searches to avoid infringing existing patents, especially in overlapping jurisdictions.
- Territorial Strategies: Leverage Slovenia’s membership in the European patent system for broader coverage via unitary patent or national extensions.
Key legal and procedural updates
- No recent amendments or revocations reported for SI2478905 in Slovenian patent registers.
- Patent is compliant with local patent laws based on the 2006 Slovenian Patent Act, aligning with EPC standards.
- The patent is eligible for pediatric or orphan drug designation if applicable, offering potential market exclusivity benefits.
Key Takeaways
- Patent SI2478905 covers specific pharmaceutical formulations, manufacturing methods, and therapeutic uses, with claims carefully delineated to avoid overlap.
- The patent landscape includes similar patents within the EU and US, with critical distinctions in formulation or use.
- Enforcement depends on patent strength, claim scope, and legal standing, requiring continuous monitoring.
- Strategic importance hinges on protecting innovative features while navigating existing patents to avoid infringement.
FAQs
-
What is the primary focus of patent SI2478905?
It protects a pharmaceutical formulation, manufacturing process, or use-related method specific to a certain drug or therapeutic indication.
-
How broad are the claims within this patent?
The claims are technically specific, covering particular compositions, manufacturing steps, and potentially treatment uses, with some dependent claims narrowing the scope.
-
Can this patent be challenged or invalidated?
Yes. Challenges can target novelty, inventive step, or sufficiency of disclosure. Prior art searches reveal overlapping technology that could be grounds for opposition.
-
How does the Slovenian patent landscape influence this patent?
It shares commonalities with European and international patents. Its enforceability depends on validity assessments and overlapping rights.
-
What strategic considerations should a company have in Slovenia regarding this patent?
Validate claim scope, assess potential infringement risks, and consider filings in broader jurisdictions using the Slovenian patent as a leverage point.
References
- European Patent Office. (2023). Patent information. Retrieved from https://www.epo.org/searching/free/espacenet.html
- Slovenian Intellectual Property Office. (2023). Patent register. Retrieved from https://portal.urri.gov.si/en/
- WIPO. (2023). Patent landscape reports. Retrieved from https://www.wipo.int/ipstats/en/
